Abstract:To analyze the treatment effect of the curcumin nanoparticle drug delivery system to the Alzheimer’s disease (AD), the NP-Cur, NP-S1-Cur, and NP-S1-Cur-CRT nanoparticles were prepared by combining the various internal water phases based on the emulsification volatilization method for the cytotoxicity test and applied to treatment of β-amyloid precursor protein/pistilloid-stamen 1 (APP/PS1) double transgenic (DT) mice in three groups, which were group W1 (treated with NP-Cur), W2 (treated with NP-S1-Cur), W3 (treated with NP-S1-Cur-CRT), W4 (treated with curcumin drugs), and W0 (normal control), respectively. Immunohistochemistry was adopted to detect the senile plaques (amyloid precursor antibody, 6E10), microglia (IBA-1), and astrocytes (glial fibrillary acidic protein, GFAP). The spatial memory ability (SMA) of mice was evaluated by the Y maze experiment, and the learning memory ability (LMA) of mice was evaluated by the new thing cognition experiment. The results showed that in the human neuroblastoma cell (SH-SY5Y), mouse brain microvascular endothelial cell line (bEnd.3), and mouse microglia cell line (BV2), the cell activity (CA) caused by NP-Cur, NP-S1-Cur, and NP-S1-Cur-CRT nanoparticles all decreased with the increase of concentration value of curcumin, but all were higher than 80%; it was found based on the Y maze experiment that the stay time (ST) and the number of entries (NE) in the group W4 were higher than those in group W1, W2, and W3 (P < 0.05); the frequency of exploring new things in the group W0 was higher than the frequency in W1, W2, and W3 (P < 0.05). There was no remarkable difference in the exploration frequency of new things in group W4 and W0 (P > 0.05); the positive units (PU values) of cytoplasm and nucleus (C&N) 6E10 protein in W4 were lower than the values in W1, W2, and W3 (P > 0.05); the PU value of C&N IBA-1 protein of W4 was lower than the value in W1, W2, and W3 (P < 0.05); the PU value of C&N GFAP protein expression in group W4 was lower obviously than the value in W1, W2, and W3 (P < 0.05). In short, poly lactic-co-glycolic acid (PLGA) nanoparticles loaded with curcumin had good biosafety and compatibility. It can effectively improve the LMA of APP/PS1 mice, reduce the area of senile plaques, and have better neuroprotective function. Among them, the NP-S1-Cur-CRT nanoparticles had the best improvement effect.

Curcumin Ameliorates Memory Deficits by Enhancing Lactate Content and MCT2 Expression in APP/PS1 Transgenic Mouse Model of Alzheimer's Disease

Curcumin Exerts Effects on the Pathophysiology of Alzheimer's Disease by Regulating PI(3,5)P2 and Transient Receptor Potential Mucolipin-1 Expression.

Curcumin alleviates Alzheimer's disease by inhibiting inflammatory response, oxidative stress and activating the AMPK pathway

Curcumin Ameliorates Lipid Metabolic Disorder and Cognitive Dysfunction Via the ABCA1 Transmembrane Transport System in APP/PS1 Double Transgenic Mice

The impacts of curcumin on learning memory function in Alzheimer’s disease under the poly lactic-co-glycolic acid nanoparticle drug carrier

Curcumin Improves Learning and Memory Ability and Its Neuroprotective Mechanism in Mice.

Curcumin Improves Amyloid Β-Peptide (1-42) Induced Spatial Memory Deficits Through BDNF-ERK Signaling Pathway

Effect of curcumin on ability of learning and memory and expression of Aβ42 in brain of APPswe/PS1dE9 double transgenic mice

Bidirectional Interactions Between Curcumin and Gut Microbiota in Transgenic Mice with Alzheimer's Disease.

Curcumin Reduces Cognitive Deficits by Inhibiting Neuroinflammation through the Endoplasmic Reticulum Stress Pathway in Apolipoprotein E4 Transgenic Mice

Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin

Curcumin Mitigates the High-Fat High-Sugar Diet-Induced Impairment of Spatial Memory, Hepatic Metabolism, and the Alteration of the Gut Microbiome in Alzheimer's Disease-Induced (3xTg-AD) Mice

Curcumin Promotes Proliferation of Adult Neural Stem Cells and the Birth of Neurons in Alzheimer's Disease Mice via Notch Signaling Pathway

A Curcumin Analog Exhibits Multiple Biologic Effects on the Pathogenesis of Alzheimer’s Disease and Improves Behavior, Inflammation, and β-Amyloid Accumulation in a Mouse Model

Potential therapeutic effects of curcumin: relationship to microtubule-associated proteins 2 in Aβ1-42 insult.

Downregulation of PI3K/Akt/mTOR signaling pathway in curcumin-induced autophagy in APP/PS1 double transgenic mice.

Curcumin Improves Neurogenesis in Alzheimer's Disease Mice via the Upregulation of Wnt/β-Catenin and BDNF

Curcumin Attenuates Lipopolysaccharide-Induced Neuroinflammation and Memory Deficiency by Inhibiting Microglia Activation in Mice Hippocampus

Antioxidant, anti‐inflammatory and epigenetic potential of curcumin in Alzheimer's disease

Neuroprotective Effects of Curculigoside Against Alzheimer’s Disease Via Regulation Oxidative Stress Mediated Mitochondrial Dysfunction in L-Glu-exposed HT22 Cells and APP/PS1 Mice

Effect of Plant Compound Curcumin on the Expression of SR-BI and ABCA1 in Hippocampal Neurons of APPswe/PS1dE9 Double Transgenic Mice